The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies
Open accessAbstract
The adult form of attention-deficit/hyperactivity disorder has a prevalence of up to 5% and is the most severe long-term outcome of this common disorder. Family studies in clinical samples as well as twin studies suggest a familial liability and consequently different genes were investigated in association studies. Pharmacotherapy with methylphenidate (MPH) seems to be the first-line treatment of choice in adults with attention-deficit hyperactive disorder (ADHD) and some studies were conducted on the genes influencing the response to this drug. Finally some peripheral biomarkers were identified in ADHD adult patients. We believe this work is the first systematic review and meta-analysis of candidate gene association studies, pharmacogenetic and biochemical (metabolomics) studies performed in adults with ADHD to identify potential genetic, predictive and peripheral markers linked specifically to ADHD in adults. After screening 5129 records, we selected 87 studies of which 61 were available for candidate gene association studies, 5 for pharmacogenetics and 21 for biochemical studies. Of these, 15 genetic, 2 pharmacogenetic and 6 biochemical studies were included in the meta-analyses. We obtained an association between adult ADHD and the gene BAIAP2 (brain-specific angiogenesis inhibitor 1-associated protein 2), even after Bonferroni correction, with any heterogeneity in effect size and no publication bias. If we did not apply the Bonferroni correction, a trend was found for the carriers allele 9R of dopamine transporter SLC6A3 40 bp variable tandem repeat polymorphism (VNTR) and for 6/6 homozygotes of SLC6A3 30 bp VNTR. Negative results were obtained for the 9-6 haplotype, the dopamine receptor DRD4 48 bp VNTR, and the enzyme COMT SNP rs4680. Concerning pharmacogenetic studies, no association was found for the SLC6A3 40 bp and response to MPH with only two studies selected. For the metabolomics studies, no differences between ADHD adults and controls were found for salivary cortisol, whereas lower serum docosahexaenoic acid (DHA) levels were found in ADHD adults. This last association was significant even after Bonferroni correction and in absence of heterogeneity. Other polyunsaturated fatty acids (PUFAs) such as AA (arachidonic acid), EPA (eicosapentaenoic acid) and DyLA (dihomogammalinolenic acid) levels were not different between patients and controls. No publication biases were observed for these markers. Genes linked to dopaminergic, serotoninergic and noradrenergic signaling, metabolism (DBH, TPH1, TPH2, DDC, MAOA, MAOB, BCHE and TH), neurodevelopment (BDNF and others), the SNARE system and other forty genes/proteins related to different pathways were not meta-analyzed due to insufficient data. In conclusion, we found that there were not enough genetic, pharmacogenetic and biochemical studies of ADHD in adults and that more investigations are needed. Moreover we confirmed a significant role of BAIAP2 and DHA in the etiology of ADHD exclusively in adults. Future research should be focused on the replication of these findings and to assess their specificity for ADHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Self-citationMeta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
FARAONE, S. V., BIEDERMAN, J., & MICK, E. (2006) · Psychological Medicine · doi:10.1017/s003329170500471x · Cited by 2,267
Self-citationThe Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Willcutt, E. G. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0135-8 · Cited by 2,160
Polanczyk, G. V., Willcutt, E. G., Salum, G. A., Kieling, C., & Rohde, L. A. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt261 · Cited by 1,822
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601
Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Self-citationMolecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411
Self-citationLesch, K.-P., Timmesfeld, N., Renner, T. J., Halperin, R., Röser, C., Nguyen, T. T., Craig, D. W., Romanos, J., Heine, M., Meyer, J., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0119-3 · Cited by 374
Van Veen, M. M., Kooij, J. J. S., Boonstra, A. M., Gordijn, M. C. M., & Van Someren, E. J. W. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.032 · Cited by 300
Research works printed but not linked: 111
- Wilens TE, Faraone SV, Biederman J . Attention-deficit/hyperactivity disorder in adults. JAMA 2004; 292: 619–623. · DOI · Paper page
- Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA . The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007; 164: 942–948. · DOI · Paper page
- Ramos-Quiroga JA, Nasillo V, Fernández-Aranda F, Casas M . Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother 2014; 14: 553–567. · DOI
- Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Hammerle M et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry 2015; 172: 967–977. · DOI · Paper page
- Katzman MA, Sternat T . A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder. CNS Drugs 2014; 28: 1005–1033. · DOI
- Sugrue D, Bogner R, Ehret MJ . Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder. Am J Health Syst Pharm 2014; 71: 1163–1170. · DOI
- Simon N, Rolland B, Karila L . Methylphenidate in adults with attention deficit hyperactivity disorder and substance use disorders. Curr Pharm Des 2015; 21: 3359–3366. · DOI
- Martin J, O'Donovan MC, Thapar A, Langley K, Williams N . The relative contribution of common and rare genetic variants to ADHD. Transl Psychiatry 2015; 5: e506. · DOI · Paper page
- Kan KJ, Dolan CV, Nivard MG, Middeldorp CM, van Beijsterveldt CE, Willemsen G et al. Genetic and environmental stability in attention problems across the lifespan: evidence from the Netherlands twin register. J Am Acad Child Adolesc Psychiatry 2013; 52: 12–25. · DOI
- Larsson H, Asherson P, Chang Z, Ljung T, Friedrichs B, Larsson JO et al. Genetic and environmental influences on adult attention deficit hyperactivity disorder symptoms: a large Swedish population-based study of twins. Psychol Med 2013; 43: 197–207. · DOI · Paper page
- Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM et al. Genetic epidemiology of attention deficit hyperactivity disorder (ADHD index) in adults. PLoS One 2010; 5: e10621. · DOI · Paper page
- Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A et al. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1996; 35: 343–351. · DOI · Paper page
- Faraone SV, Biederman J, Monuteaux MC . Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet Epidemiol 2000; 18: 1–16. · DOI · Paper page
- Brikell I, Kuja-Halkola R, Larsson H . Heritability of attention-deficit hyperactivity disorder in adults. Am J Med Genet B Neuropsychiatr Genet 2015; 30; doi: 10.1002/ajmg.b.32335. · DOI
- Gizer IR, Ficks C, Waldman ID . Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 2009; 126: 51–90. · DOI · Paper page
- Hawi Z, Cummins TD, Tong J, Johnson B, Lau R, Samarrai W et al. The molecular genetic architecture of attention deficit hyperactivity disorder. Mol Psychiatry 2015; 20: 289–297. · DOI · Paper page
- Gao Q, Liu L, Qian Q, Wang Y . Advances in molecular genetic studies of attention deficit hyperactivity disorder in China. Shanghai Arch Psychiatry 2014; 26: 194–206.
- Li Z, Chang SH, Zhang LY, Gao L, Wang J . Molecular genetic studies of ADHD and its candidate genes: a review. Psychiatry Res 2014; 219: 10–24. · DOI
- Bruxel EM, Akutagava-Martins GC, Salatino-Oliveira A, Contini V, Kieling C, Hutz MH et al. ADHD pharmacogenetics across the life cycle: new findings and perspectives. Am J Med Genet B Neuropsychiatr Genet 2014; 165B: 263–282. · DOI
- Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CH, Ramos-Quiroga JA et al. The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry 2012; 17: 960–987. · DOI · Paper page
- Sánchez-Mora C, Ribasés M, Casas M, Bayés M, Bosch R, Fernàndez-Castillo N et al. Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 600–612. · DOI
- Franke B, Vasquez AA, Johansson S, Hoogman M, Romanos J, Boreatti-Hümmer A et al. Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology 2010; 35: 656–664. · DOI · Paper page
- Johansson S, Halmøy A, Mavroconstanti T, Jacobsen KK, Landaas ET, Reif A et al. Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 1008–1015. · DOI
- Sánchez-Mora C, Ribasés M, Ramos-Quiroga JA, Casas M, Bosch R, Boreatti-Hümmer A et al. Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 512–523. · DOI
- Reif A, Nguyen TT, Weissflog L, Jacob CP, Romanos M, Renner TJ et al. DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. Neuropsychopharmacology 2011; 36: 2318–2327. · DOI
- Sánchez-Mora C, Ramos-Quiroga JA, Bosch R, Corrales M, Garcia-Martínez I, Nogueira M et al. Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder. Neuropsychopharmacology 2015; 40: 915–926. · DOI
- Akutagava-Martins GC, Salatino-Oliveira A, Genro JP, Contini V, Polanczyk G, Zeni C et al. Glutamatergic copy number variants and their role in attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2014; 165B: 502–509. · DOI
- Ramos-Quiroga JA, Sánchez-Mora C, Casas M, Garcia-Martínez I, Bosch R, Nogueira M et al. Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder. J Psychiatr Res 2014; 49: 60–67. · DOI
- Rovaris DL, Mota NR, da Silva BS, Girardi P, Victor MM, Grevet EH et al. Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. Pharmacogenomics 2014; 15: 1365–1381. · DOI
- Dresler T, Ehlis AC, Heinzel S, Renner TJ, Reif A, Baehne CG et al. Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD. Neuropsychopharmacology 2010; 35: 2193–2202. · DOI
- Ribasés M, Ramos-Quiroga JA, Hervás A, Sánchez-Mora C, Bosch R, Bielsa A et al. Candidate system analysis in ADHD: evaluation of nine genes involved in dopaminergic neurotransmission identifies association with DRD1. World J Biol Psychiatry 2012; 13: 281–292. · DOI
- de Azeredo LA, Rovaris DL, Mota NR, Polina ER, Marques FZ, Contini V et al. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults. Eur Arch Psychiatry Clin Neurosci 2014; 264: 401–408. · DOI
- Brüggemann D, Sobanski E, Alm B, Schubert T, Schmalzried H, Philipsen A et al. No association between a common haplotype of the 6 and 10-repeat alleles in intron 8 and the 3'UTR of the DAT1 gene and adult attention deficit hyperactivity disorder. Psychiatr Genet 2007; 17: 121. · DOI
- Silva MA, Cordeiro Q, Louzã M, Vallada H . Association between a SLC6A3 intron 8 VNTR functional polymorphism and ADHD in a Brazilian sample of adult patients. Rev Bras Psiquiatr 2009; 31: 390–395. · DOI
- Hoogman M, Onnink M, Cools R, Aarts E, Kan C, Arias Vasquez A et al. The dopamine transporter haplotype and reward-related striatal responses in adult ADHD. Eur Neuropsychopharmacol 2013; 23: 469–478. · DOI
- Spencer TJ, Biederman J, Faraone SV, Madras BK, Bonab AA, Dougherty DD et al. Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry 2013; 74: 84–89. · DOI
- Aparecida da Silva M, Cordeiro Q, Louzã M, Vallada H . Lack of association between a 3'UTR VNTR polymorphism of dopamine transporter gene (SLC6A3) and ADHD in a Brazilian sample of adult patients. J Atten Disord 2011; 15: 305–309. · DOI
- Hasler R, Salzmann A, Bolzan T, Zimmermann J, Baud P, Giannakopoulos P et al. DAT1 and DRD4 genes involved in key dimensions of adult ADHD. Neurol Sci 2015; 36: 861–869. · DOI
- Muglia P, Jain U, Macciardi F, Kennedy JL . Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene. Am J Med Genet 2000; 96: 273–277. · DOI
- Tovo-Rodrigues L, Rohde LA, Roman T, Schmitz M, Polanczyk G, Zeni C et al. Is there a role for rare variants in DRD4 gene in the susceptibility for ADHD? Searching for an effect of allelic heterogeneity. Mol Psychiatry 2012; 17: 520–526. · DOI
- Carpentier PJ, Arias Vasquez A, Hoogman M, Onnink M, Kan CC, Kooij JJ et al. Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes. Eur Neuropsychopharmacol 2013; 23: 448–457. · DOI
- Ghosh P, Sarkar K, Bhaduri N, Ray A, Sarkar K, Sinha S et al. Catecholaminergic gene variants: contribution in ADHD and associated comorbid attributes in the eastern Indian probands. Biomed Res Int 2013; 2013: 918410.
- Halleland H, Lundervold AJ, Halmøy A, Haavik J, Johansson S . Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 403–410. · DOI
- Biehl SC, Gschwendtner KM, Guhn A, Müller LD, Reichert S, Heupel J et al. Does adult ADHD interact with COMT val (158) met genotype to influence working memory performance? Atten Defic Hyperact Disord 2015; 7: 19–25. · DOI
- Pazvantoğlu O, Güneş S, Karabekiroğlu K, Yeğin Z, Erenkuş Z, Akbaş S et al. The relationship between the presence of ADHD and certain candidate gene polymorphisms in a Turkish sample. Gene 2013; 528: 320–327. · DOI
- Ribasés M, Bosch R, Hervás A, Ramos-Quiroga JA, Sánchez-Mora C, Bielsa A et al. Case-control study of six genes asymmetrically expressed in the two cerebral hemispheres: association of BAIAP2 with attention-deficit/hyperactivity disorder. Biol Psychiatry 2009; 66: 926–934. · DOI
- Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK et al. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1). Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 201–208. · DOI
- Mick E, Biederman J, Spencer T, Faraone SV, Sklar P . Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 890–894. · DOI
- Lackschewitz H, Huther G, Kroner-Herwig B . Physiological and psychological stress responses in adults with attention-deficit/hyperactivity disorder (ADHD). Psychoneuroendocrinology 2008; 33: 612–624. · DOI
- Raz S, Leykin D . Psychological and cortisol reactivity to experimentally induced stress in adults with ADHD. Psychoneuroendocrinology 2015; 60: 7–17. · DOI
- Young GS, Maharaj NJ, Conquer JA . Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids 2004; 39: 117–123. · DOI
- Laasonen M, Hokkanen L, Leppamaki S, Tani P, Erkkila AT . Project DyAdd: fatty acids in adult dyslexia, ADHD, and their comorbid combination. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 89–96. · DOI
- Irmisch G, Richter J, Thome J, Sheldrick AJ, Wandschneider R . Altered serum mono- and polyunsaturated fatty acid levels in adults with ADHD. ADHD Atten Def Hyp Disord 2013; 5: 303–311. · DOI
- Faraone SV, Spencer TJ, Madras BK, Zhang-James Y, Biederman J . Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Mol Psychiatry 2014; 19: 880–889. · DOI
- Smith TF . Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type. Am J Med Genet B Neuropsychiatr Genet 2010; 153B: 1189–1199. · DOI
- Lee YH, Song GG . BDNF 196 G/A and COMT Val158Met polymorphisms and susceptibility to ADHD: a meta-analysis. J Atten Disord 2015; doi: 10.1177/1087054715570389. · DOI
- Sun HJ, Yuan FF, Shen XM, Xiong GL, Wu J . Role of COMT in ADHD: a systematic meta-analysis. Mol Neurobiol 2014; 49: 251–261. · DOI
- Squassina A, Lanktree M, De Luca V, Jain U, Krinsky M, Kennedy JL et al. Investigation of the dopamine D5 receptor gene (DRD5) in adult attention deficit hyperactivity disorder. Neurosci Lett 2008; 432: 50–53. · DOI
- Muglia P, Jain U, Kennedy JL . A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder. Behav Brain Res 2002; 130: 91–95. · DOI
- Ribasés M, Ramos-Quiroga JA, Hervás A, Bosch R, Bielsa A, Gastaminza X et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry 2009; 14: 71–85. · DOI
- De Luca V, Muglia P, Jain U, Kennedy JL . No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2004; 124B: 38–40. · DOI
- de Cerqueira CC, Polina ER, Contini V, Marques FZ, Grevet EH, Salgado CA et al. ADRA2A polymorphisms and ADHD in adults: possible mediating effect of personality. Psychiatry Res 2011; 186: 345–350. · DOI
- De Luca V, Muglia P, Vincent JB, Lanktree M, Jain U, Kennedy JL . Adrenergic alpha 2C receptor genomic organization: association study in adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2004; 127B: 65–67. · DOI
- Inkster B, Muglia P, Jain U, Kennedy JL . Linkage disequilibrium analysis of the dopamine beta-hydroxylase gene in persistent attention deficit hyperactivity disorder. Psychiatr Genet 2004; 14: 117–120. · DOI
- Baehne CG, Ehlis AC, Plichta MM, Conzelmann A, Pauli P, Jacob C et al. Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals. Mol Psychiatry 2009; 14: 1032–1039. · DOI
- Jacob CP, Weber H, Retz W, Kittel-Schneider S, Heupel J, Renner T et al. Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome. J Psychiatr Res 2013; 47: 1902–1908. · DOI
- Lanktree M, Squassina A, Krinsky M, Strauss J, Jain U, Macciardi F et al. Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 945–951. · DOI
- Ribasés M, Hervás A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X et al. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 2008; 63: 935–945. · DOI
- Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry 2010; 15: 1053–1066. · DOI · Paper page
- Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Bosch R, Richarte V, Palomar G et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav 2011; 10: 149–157. · DOI · Paper page
- Mavroconstanti T, Johansson S, Winge I, Knappskog PM, Haavik J . Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients. PLoS One 2013; 8: e71445. · DOI
- Salatino-Oliveira A, Genro JP, Polanczyk G, Zeni C, Schmitz M, Kieling C et al. Cadherin-13 gene is associated with hyperactive/impulsive symptoms in attention/deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2015; 168B: 162–169. · DOI
- Herken H, Erdal ME, Kenar AN, Unal GA, Cakaloz B, Ay ME et al. Association of SNAP-25 gene Ddel and Mnll polymorphisms with adult attention deficit hyperactivity disorder. Psychiatry Investig 2014; 11: 476–480. · DOI
- Olgiati P, Mandelli L, Alberti S, Lia L, Serretti A, Tiwari AK et al. Role of synaptosome-related (SNARE) genes in adults with attention deficit hyperactivity disorder. Psychiatry Res 2014; 215: 799–800. · DOI
- Sánchez-Mora C, Cormand B, Ramos-Quiroga JA, Hervás A, Bosch R, Palomar G et al. Evaluation of common variants in 16 genes involved in the regulation of neurotransmitter release in ADHD. Eur Neuropsychopharmacol 2013; 23: 426–435. · DOI
- Kenar AN, Oİ Ay, Herken H, Erdal ME . Association of VAMP-2 and Syntaxin 1 A genes with adult attention deficit hyperactivity disorder. Psychiatry Investig 2014; 11: 76–83. · DOI
- Kenar AN, Edgünlü T, Herken H, Erdal ME . Association of synapsin III gene with adult attention deficit hyperactivity disorder. DNA Cell Biol 2013; 32: 430–434. · DOI
- Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L et al. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch Gen Psychiatry 2009; 66: 41–50. · DOI
- Kittel-Schneider S, Reuß M, Meyer A, Weber H, Gessner A, Leistner C et al. Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD. J Psychopharmacol 2015; 29: 31–38. · DOI
- De Luca V, Muglia P, Jain U, Basile VS, Sokolowski MB, Kennedy JL . A drosophila model for attention deficit hyperactivity disorder (ADHD): no evidence of association with PRKG1 gene. Neuromol Med 2002; 2: 281–287. · DOI
- Kortmann GL, Contini V, Bertuzzi GP, Mota NR, Rovaris DL, Paixão-Côrtes VR et al. The role of a mineralocorticoid receptor gene functional polymorphism in the symptom dimensions of persistent ADHD. Eur Arch Psychiatry Clin Neurosci 2013; 263: 181–188. · DOI
- Weber H, Kittel-Schneider S, Gessner A, Domschke K, Neuner M, Jacob CP et al. Cross-disorder analysis of bipolar risk genes: further evidence of DGKH as a risk gene for bipolar disorder, but also unipolar depression and adult ADHD. Neuropsychopharmacology 2011; 36: 2076–2085. · DOI
- Weber H, Scholz CJ, Jacob CP, Heupel J, Kittel-Schneider S, Erhardt A et al. SPOCK3, a risk gene for adult ADHD and personality disorders. Eur Arch Psychiatry Clin Neurosci 2014; 64: 409–421. · DOI
- Jacobsen KK, Halmøy A, Sánchez-Mora C, Ramos-Quiroga JA, Cormand B, Haavik J et al. DISC1 in adult ADHD patients: an association study in two European samples. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 227–234. · DOI
- Weißflog L, Scholz CJ, Jacob CP, Nguyen TT, Zamzow K, Groß-Lesch S et al. KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur Neuropsychopharmacol 2013; 23: 436–447. · DOI
- Jacob C, Nguyen TT, Weißflog L, Herrmann M, Liedel S, Zamzow K et al. PPP2R2C as a candidate gene of a temperament and character trait-based endophenotype of ADHD. Atten Defic Hyperact Disord 2012; 4: 145–152. · DOI
- Rebases M, Sánchez-Mora C, Ramos-Quiroga JA, Bosch R, Gómez N, Nogueira M et al. An association study of sequence variants in the forkhead box P2 (FOXP2) gene and adulthood attention-deficit/hyperactivity disorder in two European samples. Psychiatr Genet 2012; 22: 155–160. · DOI
- Contini V, Victor MM, Bertuzzi GP, Salgado CA, Picon FA, Grevet EH et al. No significant association between genetic variants in seven candidate genes and response to methylphenidate treatment in adult patients with ADHD. J Clin Psychopharmacol 2012; 32: 820–823. · DOI
- Contini V, Victor MM, Cerqueira CC, Polina ER, Grevet EH, Salgado CA et al. Adrenergic alpha 2 A receptor gene is not associated with methylphenidate response in adults with ADHD. Eur Arch Psychiatry Clin Neurosci 2011; 261: 205–211. · DOI
- Corominas M, Ribes V, Palomar G, Ramos-Quiroga JA, Ferrer R, Catalan R et al. Cortisol awakening response (CAR)in adults with attention deficit hyperactivity disorder (ADHD). Eur Psychiatry 2013; 28: 1. · DOI
- Young GS, Conquer JA, Thomas R . Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev 2005; 45: 549–558. · DOI
- Bulut M, Selek S, Bez Y, Kaya MC, Gunes M, Karababa F et al. Lipid peroxidation markers in adult attention deficit hyperactivity disorder: new findings for oxidative stress. Psychiatry Res 2013; 209: 638–642. · DOI
- Karababa IF, Savas SN, Selek S, Cicek E, Cicek EI, Asoglu M et al. Homocysteine Levels and Oxidative Stress Parameters in Patients With Adult ADHD. J Atten Disord 2014; doi: 10.1177/1087054714538657. · DOI
- Bulut M, Selek S, Gergerlioglu HS, Savas HA, Yilmaz HR, Yuce M et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2007; 32: 435–438.
- Selek S, Savas H, Gergerlioglu S, Bulut M, Yilmaz HR . Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol 2008; 79: 256–259. · DOI
- Selek S, Bulut M, Ocak AR, Kalenderoglu A, Savas H . Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. J Psychiatr Res 2012; 46: 451–455. · DOI
- Mavroconstanti T, Halmøy A, Haavik J . Decreased serum levels of adiponectin in adult attention deficit hyperactivity disorder. Psychiatry Res 2014; 216: 123–130. · DOI
- Grabemann M, Mette C, Zimmermann M, Wiltfang J, Kis B . Serum albumin correlates with affective prosody in adult males with attention-deficit hyperactivity disorder. Psychiatry Res 2014; 217: 198–201. · DOI
- Ramos-Quiroga JA, Corominas-Roso M, Palomar G, Gomez-Barros N, Ribases M, Sanchez-Mora C et al. Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine. Psychopharmacology (Berl) 2014; 231: 1389–1395. · DOI
- Reimherr FW, Wender PH, Ebert MH, Wood DR . Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in adults with attention deficit disorder, residual type. Psychiatry Res 1984; 11: 71–78. · DOI
- Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL et al. Selegiline in ADHD adults: plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997; 16: 276–284. · DOI
- Coghill DR, Banaschewski T, Lecendreux M, Soutullo C, Zuddas A, Adeyi B et al. Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial. Neuropsychiatr Dis Treat 2014; 10: 2039–2047.
- Grady DL, Chi HC, Ding YC, Smith M, Wang E, Schuck S et al. High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry 2003; 8: 536–545. · DOI · Paper page
- Sun T, Patoine C, Abu-Khalil A, Visvader J, Sum E, Cherry TJ et al. Early asymmetry of gene transcription in embryonic human left and right cerebral cortex. Science 2005; 308: 1794–1798. · DOI · Paper page
- Geschwind DH, Miller BL, DeCarli C, Carmelli D . Heritability of lobar brain volumes in twins supports genetic models of cerebral laterality and handedness. Proc Natl Acad Sci USA 2002; 99: 3176–3181. · DOI · Paper page
- Thompson PM, Cannon TD, Narr KL, van Erp T, Putanen VP, Huttunen M et al. Genetic influences on brain structure. Nat Neurosci 2001; 4: 1253–1258. · DOI · Paper page
- Smalley SL, Loo SK, Yang MH, Cantor RM . Toward localizing genes underlying cerebral asymmetry and mental health. Am J Med Genet B Neuropsychiatr Genet 2005; 135: 79–84. · DOI
- Oades RD . Frontal, temporal and lateralized brain function in children with attention-deficit hyperactivity disorder: a psychophysiological and neuropsychological viewpoint on development. Behav Brain Res 1998; 94: 83–95. · DOI
- Rogers CE, Anderson PJ, Thompson DK, Kidokoro H, Wallendorf M, Treyvaud K et al. Regional cerebral development at term relates to school-age social-emotional development in very preterm children. J Am Acad Child Adolesc Psychiatry 2012; 51: 181–191. · DOI
- Transler C, Mitchell S, Eilander A . Could polyunsaturated fatty acids deficiency explain some dysfunctions found in ADHD? Hypotheses from animal research. J Atten Disord 2013; 17: 20–28. · DOI
- Gatt JM, Burton KL, Williams LM, Schofield PR . Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res 2015; 60: 1–13. · DOI · Paper page
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“These genes are ANKK1 (Pan et al., 2015) DAT1 (Grunblatt et al., 2019b), LRP5 and LRP6 (Grunblatt et al., 2019a), SNAP25 (Liu et al., 2017b), ADGRL3 (Bruxel et al., 2020) DRD4 and BAIAP2 (Bonvicini et al., 2020, 2016).”
Self-citationGenetics of attention deficit hyperactivity disorder
Faraone, S. V., & Larsson, H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0070-0 · Cited by 1,338
Self-citationA Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
Luo, Y., Weibman, D., Halperin, J. M., & Li, X. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00042 · Cited by 394
Attention-deficit/hyperactivity disorder
Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., et al. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00495-0 · Cited by 355
Self-citationTreatment strategies for ADHD: an evidence-based guide to select optimal treatment
Caye, A., Swanson, J. M., Coghill, D., & Rohde, L. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0116-3 · Cited by 303
Metadata
- Authors
- Bonvicini, C., Faraone, S. V., & Scassellati, C.
- Venue
- Molecular Psychiatry
- Published
- 2016-05-24
- Volume
- 21
- Issue
- 7
- Pages
- 872-884
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2396652103
- Cited by
- 238
- References
- 31
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-08-09)
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. https://app.cochat.ai/papers/10.1038/mp.2016.74
- The paper
- Bonvicini, C., Faraone, S. V., & Scassellati, C. (2016). Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. Molecular Psychiatry. https://doi.org/10.1038/mp.2016.74
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.